debrisoquin has been researched along with ropivacaine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Burm, AG; Ekström, GY; Huledal, GA; Kruit, M; Stienstra, R; van Kleef, JW; Veering, BT; Wink, J | 1 |
1 trial(s) available for debrisoquin and ropivacaine
Article | Year |
---|---|
The effect of a long term epidural infusion of ropivacaine on CYP2D6 activity.
Topics: Adult; Aged; Aged, 80 and over; Amides; Analgesia, Epidural; Anesthetics, Local; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; Infusions, Parenteral; Liver; Middle Aged; Netherlands; Ropivacaine; Substrate Specificity; Sweden; Time Factors; Treatment Outcome | 2008 |
1 other study(ies) available for debrisoquin and ropivacaine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |